The single-use bioreactor market is estimated to be valued at US$ 1337.67 Mn in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
The single-use bioreactor market consists of single-use bioreactors that are employed in small-scale productions of biologics including vaccines and therapeutics. As traditional stainless steel bioreactors require extensive validation and cleaning procedures, which makes them inefficient for low volume productions. Single-use bioreactors eliminates these challenges as they are pre-sterilized and disposable which allows productions to be started quickly.

Market Dynamics:
The single-use bioreactor market is mainly driven by the technological advancements in single-use bioreactors. Biopharmaceutical manufacturers are developing novel single-use bioreactors with advanced features such as improved sensors for real-time monitoring, enhanced mixing, and aeration capabilities. For instance, in 2023 Sartorius AG launched single-use bioreactor Xcellerex XDR 2000, which features advanced sensors to monitor pH, dissolved oxygen, and temperature homogeneity.
Additionally, increasing demand for biologics such as vaccines, antibodies, and enzymes is also driving the growth of single-use bioreactor market. Growing biopharmaceutical industry and robust pipeline of biologics are increasing the need for rapid and low-cost production process of biologics, thus fueling the demand for single-use bioreactors.

SWOT Analysis

Strength: The single-use bioreactor market provides flexibility and reduces expenses. It saves space in production facilities and reduces water usage. They eliminate the need for cleaning validation and sterilization cycles between batches.

Weakness: Single-use bioreactor technologies are more expensive compared to the traditional stainless steel bioreactors. They also generate large volumes of non-recyclable plastic waste. Skill requirement and expertise are also high for handling single-use bioreactors.

Opportunity: Growing biologics manufacturing and demand for cell-based therapies present an opportunity for market growth. Increasing R&D investment in biopharmaceuticals will also boost adoption of single-use bioreactors.

Threats: Commercialization challenge of cell therapies could impact market demand. Stringent regulatory norms governing cell therapy development also poses a threat.

Key Takeaways
The global Single-Use Bioreactor Market Share is expected to witness high growth, exhibiting CAGR of 15% over the forecast period, due to increasing demand for monoclonal antibodies and gene therapies. Additionally, single-use bioreactors offer advantages such as lower capital costs, ease of scaling during clinical trials and production, and reduced risk of cross-contamination. This has accelerated their adoption over conventional stainless steel bioreactors.

Regional analysis: North America dominated the global market and accounted for around 35% of the total share in 2023. Presence of prominent market players and technological advancements are major factors driving the North American market. Asia Pacific is projected to witness fastest growth during the forecast period supported by increasing investments in biologics manufacturing and growing contract research and manufacturing organizations in China, India, and South Korea.

Key players analysis: Key players operating in the Single-Use Bioreactor Market are Sartorius AG, OmniBRx Biotechnologies, Merck KgaA, Solaris Biotechnology Srl, Eppendorf AG, Distek Inc., Celltainer Biotech BV, ABEC Inc., Thermo Fisher Scientific, and Danaher Corporation (Pall Corporation), among others. These companies are focusing on new product launches, partnerships, and expansion strategies to strengthen their market position.

Read More,

https://cmiinfopiece.blogspot.com/2023/12/ai-assisted-3d-printing-a3dp-is-fastest.html